FindTrial
Sign In

A Study Across Multiple Hospitals in India Tracking Paraquat Poisoning: Who Is Affected, How Patients Are Treated, and What Happens to Them After Treatment.

Indian Multicenter Prospective Observational Registry of Paraquat Poisoning: Epidemiology, Management Practices and Clinical Outcomes. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/112969
Enrollment
300
Registered
2026-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T603- Toxic effect of herbicides and fungicides

Interventions

Intervention1: NIL: It is an observational study Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Indian Society of Critical Care Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the confirmed cases of paraquat poisoning (Confirmed by history / positive diathionate test

Exclusion criteria

Exclusion criteria: Unconfirmed / suspected paraquat poisoning cases. Age less than 18 years. Coingestion of other poisons. Refusal of data use.

Design outcomes

Primary

MeasureTime frame
To determine ICU mortality in paraquat poisoning in IndiaTimepoint: During ICU Stay—

Secondary

MeasureTime frame
28-day mortality Development of ARDS Acute kidney injury (KDIGO criteria) Need for mechanical ventilation Length of ICU stay Treatment-related complicationsTimepoint: During ICU stay to Hospital discharge—

Countries

India

Contacts

Public ContactDr Gunjan Chanchalani

Wockhardt Hospitals LTD

Gunjan.Chanchalani@wockhardthospitals.com9757169559

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026